Japan Vietnam Medical Investment and Development JSC (HOSE: JVC)
Vietnam
· Delayed Price · Currency is VND
3,770.00
+70.00 (1.89%)
At close: Dec 20, 2024
HOSE: JVC Income Statement
Financials in millions VND. Fiscal year is April - March.
Millions VND. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | 2012 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '17 Mar 31, 2017 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | Mar '15 Mar 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | 2012 |
Revenue | 499,432 | 499,432 | 507,338 | 893,174 | 923,077 | 594,056 | Upgrade
|
Revenue Growth (YoY) | -44.08% | -1.56% | -43.20% | -3.24% | 55.39% | -22.01% | Upgrade
|
Cost of Revenue | 405,451 | 405,451 | 503,951 | 589,430 | 617,252 | 419,791 | Upgrade
|
Gross Profit | 93,981 | 93,981 | 3,386 | 303,743 | 305,824 | 174,265 | Upgrade
|
Selling, General & Admin | 120,726 | 120,726 | 1,195,390 | 43,619 | 43,765 | 38,396 | Upgrade
|
Operating Expenses | 120,726 | 120,726 | 1,195,390 | 43,619 | 43,765 | 38,396 | Upgrade
|
Operating Income | -26,745 | -26,745 | -1,192,003 | 260,124 | 262,059 | 135,869 | Upgrade
|
Interest Expense | -4,599 | -4,599 | -16,473 | -46,700 | -46,646 | -52,476 | Upgrade
|
Interest & Investment Income | 337.06 | 337.06 | 376.76 | 824.34 | 513.45 | 520.46 | Upgrade
|
Currency Exchange Gain (Loss) | -1,628 | -1,628 | -5,874 | -2,399 | - | -1,825 | Upgrade
|
Other Non Operating Income (Expenses) | 10,816 | 10,816 | 14,026 | -16,701 | 14,431 | 2,901 | Upgrade
|
EBT Excluding Unusual Items | -21,819 | -21,819 | -1,199,948 | 195,149 | 230,357 | 84,989 | Upgrade
|
Gain (Loss) on Sale of Investments | -750 | -750 | -110,750 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -7,078 | -7,078 | 1,561 | 34,627 | - | -23,652 | Upgrade
|
Asset Writedown | - | - | -26,884 | - | - | - | Upgrade
|
Pretax Income | -29,647 | -29,647 | -1,336,021 | 229,775 | 230,357 | 61,337 | Upgrade
|
Income Tax Expense | 2,047 | 2,047 | -239.13 | 54,131 | 52,569 | 19,657 | Upgrade
|
Net Income | -31,694 | -31,694 | -1,335,782 | 175,644 | 177,789 | 41,680 | Upgrade
|
Net Income to Common | -31,694 | -31,694 | -1,335,782 | 175,644 | 177,789 | 41,680 | Upgrade
|
Net Income Growth | - | - | - | -1.21% | 326.55% | -75.49% | Upgrade
|
Shares Outstanding (Basic) | 113 | 113 | 113 | 78 | 64 | 60 | Upgrade
|
Shares Outstanding (Diluted) | 113 | 113 | 113 | 78 | 64 | 60 | Upgrade
|
Shares Change (YoY) | 43.62% | - | 43.62% | 23.08% | 6.30% | 30.74% | Upgrade
|
EPS (Basic) | -281.73 | -281.73 | -11873.60 | 2242.27 | 2793.56 | 696.16 | Upgrade
|
EPS (Diluted) | -281.73 | -281.73 | -11873.60 | 2242.27 | 2793.56 | 696.16 | Upgrade
|
EPS Growth | - | - | - | -19.73% | 301.28% | -81.26% | Upgrade
|
Free Cash Flow | 33,540 | 33,540 | -327,834 | -2,188 | -49,949 | -63,840 | Upgrade
|
Free Cash Flow Per Share | 298.13 | 298.13 | -2914.07 | -27.94 | -784.84 | -1066.28 | Upgrade
|
Dividend Per Share | - | - | - | - | - | 454.546 | Upgrade
|
Gross Margin | 18.82% | 18.82% | 0.67% | 34.01% | 33.13% | 29.33% | Upgrade
|
Operating Margin | -5.36% | -5.36% | -234.95% | 29.12% | 28.39% | 22.87% | Upgrade
|
Profit Margin | -6.35% | -6.35% | -263.29% | 19.67% | 19.26% | 7.02% | Upgrade
|
Free Cash Flow Margin | 6.72% | 6.72% | -64.62% | -0.25% | -5.41% | -10.75% | Upgrade
|
EBITDA | 42,899 | 42,899 | -1,116,762 | 331,052 | 332,470 | 206,269 | Upgrade
|
EBITDA Margin | 8.59% | 8.59% | -220.12% | 37.06% | 36.02% | 34.72% | Upgrade
|
D&A For EBITDA | 69,644 | 69,644 | 75,241 | 70,927 | 70,411 | 70,400 | Upgrade
|
EBIT | -26,745 | -26,745 | -1,192,003 | 260,124 | 262,059 | 135,869 | Upgrade
|
EBIT Margin | -5.36% | -5.36% | -234.95% | 29.12% | 28.39% | 22.87% | Upgrade
|
Effective Tax Rate | - | - | - | 23.56% | 22.82% | 32.05% | Upgrade
|
Revenue as Reported | 499,432 | 499,432 | 507,338 | 893,174 | 923,077 | 594,056 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.